tiprankstipranks
Viracta Therapeutics (DE:RYI)
BERLIN:RYI

Viracta Therapeutics (RYI) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Strong Buy
15Bullish
5Neutral
2Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Viracta Therapeutics’s (RYI) Moving Averages Convergence Divergence (MACD) indicator is 0.09, suggesting Viracta Therapeutics is a Sell.
Viracta Therapeutics’s (RYI) 20-Day exponential moving average is 0.89, while Viracta Therapeutics’s (RYI) share price is €0.995, making it a Buy.
Viracta Therapeutics’s (RYI) 50-Day exponential moving average is 0.75, while Viracta Therapeutics’s (RYI) share price is €0.995, making it a Buy.

Viracta Therapeutics (RYI) Pivot Points

Apr 28, 2024, 06:32 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.95
0.96
0.98
0.99
1.01
1.02
1.04
Fibonacci
0.96
0.97
0.98
0.99
1.00
1.01
1.02
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Viracta Therapeutics (RYI) Moving Averages

Apr 28, 2024, 06:32 PM
Period
Simple
Exponential
MA5
0.97Buy
0.98Buy
MA10
0.95Buy
0.95Buy
MA20
0.89Buy
0.89Buy
MA50
0.69Buy
0.75Buy
MA100
0.57Buy
0.71Buy
MA200
0.84Buy
0.88Buy
Viracta Therapeutics’s (RYI) 10-Day exponential moving average is 0.95, while Viracta Therapeutics’s (RYI) share price is €0.995, making it a Buy.
Viracta Therapeutics’s (RYI) 100-Day exponential moving average is 0.71, while Viracta Therapeutics’s (RYI) share price is €0.995, making it a Buy.
Viracta Therapeutics’s (RYI) stock price is €0.995 and Viracta Therapeutics’s (RYI) 50-day simple moving average is 0.69, creating a Buy signal.
Viracta Therapeutics’s (RYI) stock price is €0.995 and Viracta Therapeutics’s (RYI) 100-day simple moving average is 0.57, creating a Buy signal.
Viracta Therapeutics’s (RYI) stock price is €0.995 and Viracta Therapeutics’s (RYI) 200-day simple moving average is 0.84, creating a Buy signal.

Viracta Therapeutics (RYI) Technical Indicators

Apr 28, 2024, 06:32 PM
Name
Value
Implied Action
RSI (14)
62.78
Neutral
STOCH (9,6)
59.70
Neutral
STOCHRSI (14)
74.87
Neutral
MACD (12,26)
0.09
Sell
ADX (14)
33.22
Neutral
Williams %R
-24.59
Buy
CCI (14)
108.14
Sell
ATR (14)
0.05
-
Ultimate Oscillator
63.39
Neutral
ROC
25.95
Buy
Viracta Therapeutics’s (RYI) Relative Strength Index (RSI) is 62.78, creating a Neutral signal.
Viracta Therapeutics’s (RYI) Trend Strength Indicator (ADX) is 33.22, creating a Neutral signal.
Viracta Therapeutics’s (RYI) Commodity Channel Index (CCI) is 108.14, creating a Sell signal.
Viracta Therapeutics’s (RYI) Price Rate of Change (ROC) is 25.95, creating a Buy signal.

FAQ

Is RYI a Buy, Hold, or Sell?
Based on RYI’s technical indicators, RYI is a Strong Buy.
    What is RYI’s RSI (14)?
    RYI’s RSI (14) is 62.78, which suggests RYI is a Neutral.
      What is RYI’s MACD?
      RYI’s MACD is 0.09, which suggests RYI is a Sell.
        What is RYI’s 5-day moving average?
        RYI’s 5-day moving average is 0.97, which suggests RYI is a Buy.
          What is RYI’s 20-day moving average?
          RYI 20-day moving average is 0.89, which suggests RYI is a Buy.
            What is RYI’s 50-day moving average?
            RYI’s 50-day moving average is 0.69, which suggests RYI is a Buy.
              What is RYI’s 200-day moving average?
              RYI’s 200-day moving average is 0.84, which suggests RYI is a Buy.
                What is RYI’s Williams % R (14)?
                RYI’s Williams % R (14) is -24.59, which suggests RYI is a Buy.
                  What is RYI’s CCI (14)?
                  RYI’s CCI (14) is 108.14, which suggests RYI is a Sell.
                    What is the share price of Viracta Therapeutics?
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis